Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01329198 · ClinicalTrials.gov registry record · NA
Brain Stimulation for the Treatment of Tourette Syndrome
A NA study of Tourette Syndrome, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01329198: Completed NA study of Tourette Syndrome, sponsored by University of Florida.
NCT01329198 is a NA study of Tourette Syndrome that has completed, run by University of Florida. The registered enrollment target is 5 participants, below the 87-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01329198, a NA study of Tourette Syndrome, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to determine whether a particular type of Deep Brain Stimulation (DBS), scheduled Deep Brain stimulation (SBS), is an effective and safe treatment for Tourettte syndrome (TS). The trial will also examine the brain activity associated with TS and tics and explore the possibility of responsive brain stimulation (RBS).
Primary Outcome
The Yale Global Tic Severity Scale (YGTSS) is a semistructured clinician-rated instrument that assesses the severity and frequency of motor and phonic tics over the previous week. Five index scores are obtained during the assessment, where higher scores indicate greater frequency or severity. These indices are: * Total Motor Tic Score (0-25) * Total Phonic Tic Score (0-25 * Total Tic Score (0-50) * Overall Impairment Rating (0-50) * Global Severity Score (0-7) The YGTSS Total Score is obtained
Conditions Studied
Interventions
- DEVICE NeuroPace RNS® System Deep Brain Stimulator
Study Locations (1)
Florida
- University of Florida Movement Disorders Center - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-09 |
| Est. Completion | 2017-04 |
| Phase | NA |
What the finished NCT01329198 record still lists
NCT01329198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 87-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which NeuroPace RNS® System Deep Brain Stimulator is the first listed.
NCT01329198 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01329198 about?
NCT01329198 is a clinical study titled "Brain Stimulation for the Treatment of Tourette Syndrome". The purpose of this trial is to determine whether a particular type of Deep Brain Stimulation (DBS), scheduled Deep Brain stimulation (SBS), is an effective and safe treatment for Tourettte syndrome (TS). The trial will also examine the brain activity associated with TS and tics and explore the pos...
What is the current status of trial NCT01329198?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-09. Estimated completion is 2017-04.
What conditions does trial NCT01329198 study?
This clinical trial studies the following conditions: Tourette Syndrome.
What interventions are being tested in trial NCT01329198?
The interventions under investigation include: NeuroPace RNS® System Deep Brain Stimulator (DEVICE).
Who is sponsoring clinical trial NCT01329198?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01329198 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01329198's enrollment target sits among peer trials
5 34th of 33 the lowest of 33 other Tourette Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Remote Delivery of a Mindfulness-based Intervention for Tics
RECRUITING · NA
-
Trajectories of Change in Tourette Syndrome
RECRUITING · NA
-
Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder
RECRUITING · NA
-
Strengthening Tourette Treatment OPtions Using TMS to Improve CBIT, a Double-blind, Randomized, Controlled Study
RECRUITING · NA
-
Tourette Deep Brain Stimulation (DBS) Target Detection & Suppression
ACTIVE NOT RECRUITING · NA
-
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia